欧洲药典适用性证书数据库（欧盟CEP认证）

专论编号	物质名称	证书持有人	持有人ORG-ID和LOC-ID	证书编号	发布日期	证书状态	到期续期	证书类型	上一程序的结束日期	历史数据程序类型\|结论\|日期
2777	Pregabalin	AALIDHRA PHARMACHEM PRIVATE LIMITED Nandesari IN	100042480;100070177	R0-CEP 2019-085 - Rev 02	2023/03/07	Valid	15/09/2025	Chemical	2023/03/07	Minor revision\|CEP granted\|07/03/2023; Minor revision\|CEP granted\|08/03/2022
2768	Fluticasone furoate, Process 1	CORAL DRUGS PRIVATE LIMITED New Delhi IN	100019182;100042823	R0-CEP 2021-372 - Rev 00	2023/03/07	Valid	07/03/2028	Chemical	2023/03/07	New application\|CEP granted\|07/03/2023
2858	Mometasone furoate monohydrate	TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL	100000702;100060842	R0-CEP 2022-287 - Rev 01	2023/03/07	Valid	20/02/2028	Chemical	2023/03/07	Administrative procedure\|CEP granted\|07/03/2023; New application\|CEP granted\|20/02/2023
2787	Esomeprazole magnesium dihydrate	HETERO DRUGS LIMITED Hyderabad IN	100008415;100014434	R1-CEP 2014-333 - Rev 01	2023/03/07	Valid		Chemical	2023/03/07	Notification\|CEP granted\|07/03/2023; Renewal\|CEP granted\|26/04/2022; Minor revision\|CEP granted\|11/03/2020
2616	Topiramate	HETERO DRUGS LIMITED Hyderabad IN	100008415;100014434	R0-CEP 2020-130 - Rev 01	2023/03/06	Valid	13/07/2027	Chemical	2023/03/06	Notification\|CEP granted\|06/03/2023; New application\|CEP granted\|13/07/2022
2932	Rivaroxaban	CIPLA LIMITED Mumbai IN	100006004;100018147	R0-CEP 2021-278 - Rev 00	2023/03/06	Valid	06/03/2028	Chemical	2023/03/06	New application\|CEP granted\|06/03/2023
2768	Fluticasone furoate	CORAL DRUGS PRIVATE LIMITED New Delhi IN	100019182;100042823	R0-CEP 2022-018 - Rev 00	2023/03/06	Valid	06/03/2028	Chemical	2023/03/06	New application\|CEP granted\|06/03/2023
714	Doxorubicin Hydrochloride	TRANSO-PHARM HANDELS GMBH Siek DE	100018331;100027110	R1-CEP 2004-059 - Rev 03	2023/03/06	Valid		Chemical	2023/03/06	Notification\|CEP granted\|06/03/2023; Notification\|Rejected\|09/11/2022
550	Diazoxide	MSN LABORATORIES PRIVATE LIMITED Rudraram Village IN	100011732;100018657	R0-CEP 2021-065 - Rev 00	2023/03/03	Valid	03/03/2028	Chemical	2023/03/03	New application\|CEP granted\|03/03/2023
1755	Ketorolac trometamol	VASUDHA PHARMA CHEM LIMITED Hyderabad IN	100011811;100018603	R1-CEP 2014-369 - Rev 01	2023/03/03	Valid		Chemical	2023/03/03	Minor revision\|CEP granted\|03/03/2023; Renewal\|CEP granted\|02/02/2022
391	Furosemide	MANGALAM DRUGS & ORGANICS LTD. Mumbai IN		R0-CEP 2019-063 - Rev 01	2023/03/02	Valid	07/09/2026	Chemical	2023/03/02	Major revision\|CEP granted\|02/03/2023
2445	Adapalene	BAL PHARMA LIMITED Bangalore IN	100016398;100041736	R1-CEP 2016-309 - Rev 00	2023/03/02	Valid		Chemical	2023/03/02	Renewal\|CEP granted\|02/03/2023
1829	Horse-chestnut dry extract, standardised, DER 4-6:1	SCHWABE EXTRACTA GMBH & CO. KG Karlsruhe DE	100021578;100030272	R1-CEP 2017-086 - Rev 00	2023/03/02	Valid		Herbal	2024/03/21	Notification\|Accepted - CEP remains valid\|21/03/2024; Monograph revision\|Accepted - CEP remains valid\|28/08/2023; Renewal\|CEP granted\|02/03/2023; Minor revision\|Accepted - CEP remains valid\|09/11/2021; Minor revision\|CEP granted\|30/04/2020
1765	Salmeterol xinafoate, Process I	HOVIONE FARMACIENCIA S.A. Loures PT	100001467;100000315	R1-CEP 2017-055 - Rev 01	2023/03/01	Valid		Chemical	2023/03/01	Minor revision\|CEP granted\|01/03/2023; Renewal\|CEP granted\|19/09/2022
513	Miconazole nitrate	JANSSEN PHARMACEUTICA NV Beerse BE	100000625;100005958	R2-CEP 1995-008 - Rev 04	2023/03/01	Valid		Chemical	2023/09/21	Notification\|Accepted - CEP remains valid\|21/09/2023; Administrative procedure\|CEP granted\|01/03/2023; Minor revision\|CEP granted\|09/12/2022
1368	Ramipril, RMP	EGIS Pharmaceuticals PLC Budapest HU	100001091;100001662	R0-CEP 2020-284 - Rev 01	2023/02/28	Valid	19/03/2026	Chemical	2023/02/28	Notification\|CEP granted\|28/02/2023; New application\|CEP granted\|19/03/2021
2306	Gemcitabine hydrochloride, GA process	HETERO LABS LIMITED Hyderabad IN	100011681;100018664	R0-CEP 2022-499 - Rev 00	2023/02/28	Valid	28/02/2028	Chemical	2023/02/28	New application\|CEP granted\|28/02/2023
2306	Gemcitabine hydrochloride	JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. Lianyungang City CN		R1-CEP 2017-076 - Rev 00	2023/02/28	Valid		Chemical	2023/02/28	Renewal\|CEP granted\|28/02/2023
2606	Tadalafil, Process II	MYLAN LABORATORIES LIMITED Hyderabad IN	100011537;100018667	R0-CEP 2019-201 - Rev 01	2023/02/27	Valid	20/12/2024	Chemical	2023/02/27	Minor revision\|CEP granted\|27/02/2023
662	Daunorubicin Hydrochloride	DZD (HEZE) PHARMACEUTICAL CO., LTD. Heze City CN	100039412;100062056	R1-CEP 2016-253 - Rev 01	2023/02/27	Valid		Chemical	2023/02/27	Monograph revision\|CEP granted\|27/02/2023; Renewal\|CEP granted\|19/10/2022

专论编号 (Monograph Number)
物质名称 (Substance)
证书持有人 (Certificate (CEP) Holder)
证书编号 (Certificate (CEP) Number)
证书类型 (Type CEP)
证书状态 (Status CEP)
发布日期(Issue Date CEP)	-
证书效期(End date CEP)	-